Literature DB >> 15170469

Overcoming resistance.

Caroline Hadley.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15170469      PMCID： PMC1299089          DOI： 10.1038/sj.embor.7400181

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Variation in European antibiotic use.

Authors:  S Coenen; M M Kuyenhoven; C C Butler; P Van Royen; T J Verheij
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

2.  Variation in antibiotic use in the European Union.

Authors:  O Cars; S Mölstad; A Melander
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

3.  The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development.

Authors:  Andrew Moore
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

4.  Health-care system frailties and public health control of communicable disease on the European Union's new eastern border.

Authors:  Richard J Coker; Rifat A Atun; Martin McKee
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

5.  Communicable disease surveillance and management in a globalised world.

Authors:  David N Durrheim; Rick Speare
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.